메뉴 건너뛰기




Volumn 102, Issue 4, 2011, Pages 241-243

Intermittent treatment regimens and the rational (efficient) use of biologic agents in psoriasis;Uso racional (eficiente) de biológicos y terapia intermitente en psoriasis

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL THERAPY; CLINICAL EFFECTIVENESS; HUMAN; NOTE; PSORIASIS;

EID: 79955014003     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S1578-2190(11)70798-3     Document Type: Note
Times cited : (3)

References (8)
  • 2
    • 79955032242 scopus 로고    scopus 로고
    • Ley 29/2006, de 26 de julio, de garantías y uso racional de los medicamentos y productos sanitarios. BOE n° 178, de 27 de julio de 2006.
    • Ley 29/2006, de 26 de julio, de garantías y uso racional de los medicamentos y productos sanitarios. BOE n° 178, de 27 de julio de 2006.
  • 3
    • 79955032901 scopus 로고    scopus 로고
    • Inforcoan. Sistema de Contabilidad Analítica de Hospitales y Distritos. Servicio Andaluz de Salud. Sevilla: Consejería de Salud, Junta de Andalucía; 2009.
    • Inforcoan. Sistema de Contabilidad Analítica de Hospitales y Distritos. Servicio Andaluz de Salud. Sevilla: Consejería de Salud, Junta de Andalucía; 2009.
  • 4
    • 39149087698 scopus 로고    scopus 로고
    • The effect of weight on the efficacy of biologic therapy in patients with psoriasis
    • L. Clark, and M. Lebwohl The effect of weight on the efficacy of biologic therapy in patients with psoriasis J Am Acad Dermatol. 58 2008 443 446
    • (2008) J Am Acad Dermatol. , vol.58 , pp. 443-446
    • Clark, L.1    Lebwohl, M.2
  • 5
    • 79551488770 scopus 로고    scopus 로고
    • Adalimumab for moderate to severe chronic plaque psoriasis: Efficacy and safety of retreatment and disease recurrence following withdrawal from therapy
    • K. Papp, J. Crowley, J.P. Ortonne, J. Leu, M. Okun, and S.R. Gupta Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy Br J Dermatol. 164 2011 434 441
    • (2011) Br J Dermatol. , vol.164 , pp. 434-441
    • Papp, K.1    Crowley, J.2    Ortonne, J.P.3    Leu, J.4    Okun, M.5    Gupta, S.R.6
  • 6
    • 77954198236 scopus 로고    scopus 로고
    • Treating psoriasis with etanercept in italian clinical pactice. Prescribing practices and duration of remission following discontinuation
    • A. Arcese, N. Aste, Bettacchini, Camplone, F. Cantoresi, and M. Caproni Treating psoriasis with etanercept in italian clinical pactice. Prescribing practices and duration of remission following discontinuation Clin Drug Invest. 30 2010 507 516
    • (2010) Clin Drug Invest. , vol.30 , pp. 507-516
    • Arcese, A.1    Aste, N.2    Bettacchini3    Camplone4    Cantoresi, F.5    Caproni, M.6
  • 8
    • 58349101307 scopus 로고    scopus 로고
    • Economic evaluation of etanercept in the management of chronic plaque psoriasis
    • A. Lloyd, P. Reeves, P. Conway, A. Reynolds, and G. Baxter Economic evaluation of etanercept in the management of chronic plaque psoriasis Br J Dermatol. 160 2009 380 386
    • (2009) Br J Dermatol. , vol.160 , pp. 380-386
    • Lloyd, A.1    Reeves, P.2    Conway, P.3    Reynolds, A.4    Baxter, G.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.